CJPR

Previous Articles     Next Articles

  

  • Online:2015-07-01 Published:2015-06-30

转移性乳腺癌外科手术应用价值及选择

刘荫华高国璇   

  1. 北京大学第一医院乳腺疾病中心,北京100034

Abstract:

Option and status of the surgical intervention in the treatment of metastatic breast cancer        LIU Yin-hua, GAO Guo-xuan. Breast Disease Center,Peking University First Hospital,Beijing100034,China
Corresponding author:GAO Guo-xuan,E-mail:aliceggx@163.com
Abstract    The treatment of breast cancer has been standard. Early breast cancer can reach a long overall survival after combined treatment including surgery, chemotherapy, targeted therapy, endocrine therapy and radiotherapy. Metastatic breast cancer including metastasis at diagnosis and relapse and metastasis has a low five-year survival rate(24%),of which non-surgical treatment has clear guidelines of formulation. But the option and status of the surgical intervention in the treatment of metastatic breast cancer are always being controversial.

Key words: metastatic breast cancer, surgical intervention

摘要:

乳腺癌总体诊治理念已日臻规范,尤其是早期乳腺癌通过手术、化疗、放疗、靶向药物治疗以及内分泌治疗等系统性治疗后可以获得长期无病生存。但是,转移性乳腺癌(首诊Ⅳ期及复发、转移)多数仍然无法治愈,其5年存活率仅为24%。关于转移性乳腺癌优先选择化疗、内分泌治疗和靶向药物治疗等系统性全身治疗已有共识,而针对转移性乳腺癌外科干预的适应证、目的和时机仍然存在分歧。

关键词: 转移性乳腺癌, 外科手术